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The Surface ofa Small Cell
To the naked eye it is a milky liquid in a test tube. But when
a droplet of it is seen through the thousandfold magnifying
power of the microscope in Alexander Tomasz's laboratory, the
field of vision suddenly becomes filled with hundreds of foot-
ball-like objects, remarkably uniform in shape and size, some
of them arranged in pairs, some aligned tip-to-tip like a
necklace.
"You are looking at pneumococci," explains Dr. Tomasz,
"bacteria that are among the most dangerous agents of human
disease. You are also looking at the microbe that provided the
clues to what many consider the most important discovery of
biology in this century: the identification of DNA as the mat-
erial of the genes."
In the preantibiotic era, up to the 1940s, pneumococcal
infection was a leading cause of death, surpassing heart disease
and cancer. Even with the introduction of penicillin, the
pneumococcus has remained a major killer of children. Not
surprisingly, many of the first generation of biologists and
chemists at what was originally known as The Rockefeller Insti-
tute for Medical Research concentrated on learning more about
the pneumococcus. Their efforts were rewarded with some of
the most important landmarks of microbiology, including the
chemical characterization of the first polysaccharide antigen,
the sugary "coat" that enables bacteria to evade a host's immune
defenses. The crowning achievement to emerge from




Elaine Tuomanen reading a
computer printout that shows the
growth ofpneumococcal cultures
and their death by penicillin.
Simplified diagram of the pneumococcal cell wall, layers offibers
composedofchains ofsugars (G and M), interlinkedby shortpeptides
(made of amino acids), shown in orange. (G = glucosamine.
M = muramic acid.)
The small black balls represent other types of sugar chains, an
important component of which is choline, essential to normal cell
growth.
PBPs, penicillin-binding proteins. Responsible for building cell
walls, these proteins are the targets ofpenicillin action.
pneumococcal research at The Rockefeller-the demonstration
that DNA was the molecular carrier of heredity-was reported
by Oswald Avery, Colin Macleod, and Maclyn McCarty in
1944.
The circledareas represent specific chemicalgroupings on the bacterial
cell wall that are "recognized" by an invaded host and that:
(1) provoke capillary bleeding and inflammation;
(2) trigger the immune system;
(3) serve as an attachment sitefor proteins ofcomplement, a substance
important in host defense;
(4) activate complement before attachment;
(5) react with the so-calledC-reactiveprotein, which is producedin
large amounts in the blood during infection but the function of
which is still unclear. This part ofthe wall also contains choline,
the receptorjorautolysin, the enzyme which, when activated by
penicillin, causes the pneumococcus to explode.
"Ironically," Dr. Tomasz remarks, "the original question ad-
dressed by the early studies, namely, how do as few as a hundred
of these tiny bacteria kill a child, has remained unanswered."
For the past several years, Dr. Tomasz's laboratory has been
readdressing this question. 'Tm convinced," he says, "that the
answers lie in a better understanding of the chemistry of the
pneumococcal surface, specifically, the outermost layer called
the cell wall.
"What fascinates me about the cell wall," he says, "is the
improbable nature and number of tasks it has to perform. It
has to be rigid enough to maintain the integrity of the cell.
It has to reproduce itself, in perfect replicas, in each cell divi-
sion. And it has to regulate tbe opening and closing of its
many gates, doors, and windows to allow the orderly traffic of
thousands of nutrient molecules in and out of the cell every
second. It also serves as the cell's communication center, receiv-
ing and transmitting signals from and to the outside world. "
A slender band measuring about a thousandth ofa millimeter
and visible only through the electron microscope, the cell wall
is, in fact, an enormous molecular envelope, conforming to
the size and shape of the cell and surrounding the entire cell
with an uninterrupted protective network of chemical bonds.
Bacterial walls represent the largest molecules in nature. Bac-
teria can reproduce these "miniature architectural master-
pieces," as Dr. Tomasz calls them, with speed and precision in
each cell division. He notes: "I often watch and admire the
logistics that go into the construction of a building in New
York. Imagine a house already inhabited and yet under continu-
ous expansion with such miraculous efficiency that a new, iden-
tical twin structure arises every halfhour without inconveniencing
the tenants."
BAcrERIA TALKING TO ONE ANarHER
Hungarian-born Alexander Tomasz briefly considered a career
in music before deciding to study biology and chemistry at the
University of Budapest. He fled to Austria after the Soviet
suppression of the Hungarian uprising in 1956, crossing the
border hidden in a canvas-covered farm truck. Shortly after, he
came to New York.
"Like so many other refugees," he says, "I came with only
the clothes 1 wore. After 1 had found a job as a technician at
Sloan-Kettering Institure and a small flat, I invested my first
paycheck in some clothes, a record player, and two favorite
recordings-the Bach double concerto for violins and the Mass
in B Minor. Furniture came later."
Resuming his scientific education, he earned a Ph. D. in
biochemistry at Columbia University. "My mind was only vag-
uely set as to what 1 wanted to do nexr. I was interested in
two subjects, molecular genetics and the surfaces of cells."
The pneumococcus has the capacity, rare among bacteria, to
take up free-floating strands of DNA from its environment.
This capacity was dubbed "competence" by the investigators
who took advantage of it in studying the mechanisms by which
nonvirulent pneumococci are transformed by absorbing DNA
molecules from virulent neighbor pneumococci (which led to
the recognition of DNA as the genetic bearer).
Through his reading, Dr. Tomasz came upon the perfect
problem to engage both his interests: how pneumococci capture
DNA molecules during the process of genetic transformation.
It was clear that the place to approach it was The ,Rockefeller
University laboratory of Rollin Hotchkiss, whose group had
made enormous advances in refining the discovery of Avery,
Macleod, and McCarty.
"The reputation of the place was formidable," says Dr. To-
masz. "I still remember my interview with Hotchkiss. At the
end of it 1 was so excited that 1 inadvertantly put on his.
somewhat oversized galoshes instead of my own. Hotchkiss
observed with quiet amusement and then asked, 'How does it
feel to be in my shoes?'"
The work on competence started out with "a lot of frustra-
tion," Dr. Tomasz recalls. "Most people in the field were in-
terested in it simply as a technique to assess the quality of the
DNA molecule. I was at heart a cell biologist. I was interested
in the competent cell itself. 1 wanted to know what special
properties of the pneumococcus enable it to recognize bare
DNA floating by. Are there special entry points, special doors
on the cell surface? Could one see them?"
Soon after his arrival, he consulted with Walther Stoeckenius,
now a professor of biophysics at the University of California,










) I , "'"'-#~, . .
Scanning electron micrograph of
pneumococcal cells stuck together
in long chains. The inhibition of
normal cell division is one ofthe
consequences 'when the bacteria are
grown in a medium containing
the abnormal compound
ethanolamine inplace ofcholine.
Another consequence is penicillin
tolerance.
DNA molecules and, by means of a special technique new at
the time, see both cells and molecules in the electron micro-
scope. ,
"I will never forget my excitement and amazement when,
after searching and searching in vain, I suddenly saw the contour
of a long, slender fiber of DNA attached to the side of a
pneumococcus. I knew that I was fortunate to have caught a
cell at the moment of uptake. I ran into the hall and called
everyone in to look." (The micrograph has since appeared in
several microbiology textbooks.)
Despite his thrill and "aesthetic satisfaction" he still hadn't
found the "door" he was looking for. ':As it turned out," he
says, "I was soon to find the 'key' for the door, but the nature
of the door itself has remained pretty much an enigma."
It had been known for some time that in pneumococcal
cultures passing through a typical growth cycle the ability to
take up DNA emerged in a peculiar manner. At low cell con-
centrations competence was undetectable. Then, as the cells
multiplied, it appeared abruptly and spread through the culture
until virtually every cell was catching DNA from the medium.
Dr. Tomasz wondered whether the sudden and synchronous
sweep of competence could possibly result from the expression
of a physiological state, some kind of temporary "differentia-
tion" enforced by some factor produced by one cell and trans-
mitted to another. Is it possible that these bacteria "talk" to
each other?
His experiments confirmed his hunch. He discovered a highly
specific factor released by competent cells-a protein he called
"activator"-which could then induce competence in other
cells that were not yet competent. "Therefore, the commu-
nication on the genetic level, that is, the uptake of DNA
molecules," he says, "appears to be preceded by another type
of physiological 'communication' alerting and preparing cells
to receive and allow the entry of DNA molecules. Interactions
between groups of cells, via hormone chemical messengers, is
common among multicellular organisms, but this type of
mechanism had not been seen before in bacteria."
Dr. Tomasz remembers that just at that time Dr. Hotchkiss
had published a historical paper on Avery. "He took out his
pen and wrote on a reprint of it, 'To Alex Tomasz, Avery's
grandson.' When I reminded him that Avery had never married,
he promptly corrected the dedication, 'To Alex Tomasz, Avery's
illegitimate grandson.' "
With activator in hand, Dr. Tomasz started a series of exper-
iments to understand, in biochemical terms, what this sub-
stance actually does to cells. It was clear that activator was
some sort of a key that opened a door on the cell wall through
which DNA molecules could now move inward and attach to
receptors located somewhere deeper under the cell surface.
SUICIDAL ENZYMES
While searching for the DNA receptor, Dr. Tomasz came upon
a chemical compound, called choline, common in higher or-
ganisms, but which had not been seen before in bacterial cell
walls. He further discovered that it was essential to the
pneumococcus. Without choline in the culture medium the
bacteria did not grow. When he tried to feed the cells some
different but related compounds, the results were "astonishing."
Ethanolamine was one of the compounds the cells accepted.
As the wall was built, the ethanolamine took up the position
normal to choline, but the cells in which they did so lost the
ability to perform many activities. Daughter cells were unable
to separate at the end of division, the cells could no longer
take up DNA, even when treated with activator, and most
interestingly, they did not blow apart when treated with penicil-
lin. Dr. Tomasz knew he had "struck gold."
The internal pressure of a bacterial cell is almost always
greater than that of its surrounding milieu. It would therefore
instantly explode were it not for the strong, supportive fibers
of the wall that encase it with an uninterrupted network of
chemical bonds. If the continuity of this network is broken,
as seems to happen in penicillin-treated cells, the contents of
the cell bursts out, or lyses.
Several years of study in the laboratory revealed that choline
serves as the receptor to which an enzyme called autolysin
attaches when it receives the "go" signal to start breaking
chemical bonds in the cell-wall network. Dr. Tomasz and his
co-workers think that the command is normally released at the
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Dr. Tomasz} laboratory assistant
Jill Schwartz, and Dr.
Tuomanen studying fluorograms
ofpenicillin-binding proteins
from South African strains of
penicillin-resistant pneumococci.
The bacteria were given penicillin
tagged with radioactive tritium,
which reacts with the penicillin-
bindingproteins to form a complex
that can be visualized on X ray
film.
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Marilyn Chung, who is assisting
with biochemical analyses of
pneumococcal cell walls.
end of cell division so the autolysin can split fibers to complete
the separation of daughter cells. When the choline receptors
were missing, the autolysin could not obey the go command
and thus dali~hter cells remained linked to one another forming
infinitely long chains.
"Most exciting," says Dr. Tomasz, "was the evidence that
the destructive secret of penicillin lies in its ability to fool the
bacteria into releasing the signal at the wrong time, on the
wrong scale, and at the wrong places along the cell surface,
thereby causing bacerial suicide. When pneumococci with in-
hibited autolysis (in which ethanolamine replaced choline) were
treated with penicillin, the cells didn't explode, but just stopped
growing and died more slowly."
He named this phenomenon "antibiotic tolerance." Since
his initial description, penicillin-tolerant mutants have been
observed among many different kinds of pathogenic bacteria
isolated from patients. "These mutants may be causing compli-
cations in the treatment of patients with defective immune
systems, or in heart-valve infection or meningitis, body sites
that are poorly accessible to the immune system."
ARMAMENTS RACE
In 1977, South African scientists described an epidemic caused
by a new and frightening breed of pneumococcus that had
become over a thousand times more resistant to penicillin than
any pneumococci before. Many of the strains had also acquired
resistance to other antibiotics, making traditional therapies
useless in diseases such as pneumococcal meningitis.
Specimens of the South African strains were sent to Dr.
Tomasz. In the course of studying them, Sonia Zighelboim of
his laboratory group discovered a new bacterial ploy. It was not
the familiar trick of producing an enzyme that can destroy
penicillin, which had been seen, for example, in staphyloccoccal
infections. These pneumococci had managed an even more
herculean feat. They had rebuilt the target proteins of the
antibiotic.
"The normal job of such proteins, which are enzymes, is to
take the 'bricks' constantly emerging from inside the cell and
bolt them to the growing wall," Dr. Tomasz explains. "They
work in a kind of assembly line. If you confuse or inhibit even
one of them, by genetic manipulation or by drugs, the result
is a bacteria with a totally different shape. Footballs become
long spaghetti or round potatoes."
Penicillin's devastating effect on bacteria is due to the fact
that it is mistaken by the wall-assembly proteins for the bricks.
The antibiotic molecules thus gain entry into the labyrinths
of these proteins, reaching the active center of the enzyme and
inactivating it by the formation of complexes called penicillin-
binding proteins.
A thorough study of the penicillin-binding proteins of the
South African pneumococci revealed that they had undergone
subtle alterations, or mutations, in their DNA blueprints. As
a result, the cavities in the wall-assembly proteins were so
deformed they impeded inward passage of the penicillin
molecule. Dr. Tomasz's laboratory is now working with a group
of chemists who are trying to remodel the shape of antibiotic
molecules in order to refit them into the remodeled bacterial
enzymes. .
The appearance of penicillin resistance among pneumococci
and other pathogens represented a new stage in the armaments
race between bacteria and science. "One of the important lessons
bacteria have taught us," says Dr. Tomasz, "is that they are
capable of many ingenious methods of counteracting the
weapons deployed against them."
An extremely interesting puzzle posed by resistance is cur-
rently being studied in Dr. Tomasz's laboratory by Jose Garcia-
Bustos. Reasoning that if the antibacterial activity of penicillin
is based on the structural similarity between parts of the anti-
biotic molecule and parts of the cell-wall building block--so
much so that the wall-building enzymes mistake one for the
other-then one may expect that resistant cells with abnormal
penicillin-binding proteins may have to pay a price for their
resistance, for example, by having to build slightly different
walls. Dr. Garcia-Bustos is currently comparing walls of resis-
tant and sensitive cells, applying highly sophisticated biochem-
ical analysis in the hope of developing a high resolution map
of the chemistry of the pneumococcal cell wall. "What he
learns," says Dr. Tomasz, "will benefit all our studies in this
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area, since all the miraculous properties of the pneumococcal
cell wall ultimately depend on the chemical fine structure and
topography of the pneumococcal surface."
BACfERIA TALKING TO HUMAN CELLS
Before the development of antibiotics, almost half of all
pneumococcal lung infections and nearly all cases of meningitis
were fatal. With the introduction of penicillin, the percentages
dropped dramatically, but the pneumococcus is still a serious
threat. Mortality from pneumococcal meningitis remains
greater than thirty percent.
Elaine Tuomanen, a medical graduate of McGill University
and a member of Dr. Tomasz's laboratory since 1981, arrived
with clinical experience in pediatric infections and a desire to
study the body's reactions to bacterial invaders using animal
models of disease.
Many symptoms of bacterial disease can be traced to molecu-
lar events and interactions between the sunace of the bacterial
pathogen and the host. Just as pneumococci can recognize
DNA molecules and "talk" to each other with the signals of
activator, they can also recognize a spectrum of important host
molecules and send signals to human cells, which respond with
the alarm "sirens and bells" of an invaded host. This molecular-
level dialogue constitutes "disease."
Dr. Tuomanen is also exploring the added dimensions of
complexity the environment ofa living being adds to the mode
of action of antibiotics; what happens, for example, when the
explosion of a bacteria, triggered by penicillin, occurs not in
a test tube but in the brain of a patient with meningitis. "We've
long been puzzled," she says, "by the fact that meningitis
patients sometimes die even after penicillin has destroyed all
the invading pneumococci."
Working with rabbits, Dr. Tuomanen has found evidence
that when the bacteria blow themselves apart what was one
invader is now sensed by the immune system as thousands.
Each fragment of debris, mostly pieces of cell wall, attracts
white cells in enormous numbers. The inflammation this causes
in the limited cerebrospinal fluid space puts dangerous pressure
on the brain. She has been experimenting with the use of
nonsteroidal anti-inflammatory drugs combined with penicillin
to protect against this overreaction. Her hope is that the en-
couraging results she has had with rabbits will hold true with
children.
"Some of the most intriguing events of infection," Dr.
Tuomanen says, "are those that occur before the immune response
begins. How do bacteria gain a foothold in the host? How
does the host recognize an invader's presence? If we could inter-
vene in these first steps, we might be able to develop new
therapeutic strategies."
A model for such an approach is emerging from her studies
with another bacterial pathogen, Bordetella pertussis, which
causes whooping cough, or pertussis, a highly contagious and
potentially fatal disease. The widely administered DTP vaccine
(for diptheria, tetanus, and pertussis) has a high rate of side
effects, and some parents have become wary of having their
children innocoulated. As a result, whooping cough is on the
rise in England, Japan, and the United States.
In contrast to the pneumococcus, which invades compart-
ments of the body, Bordetella does its damage while clinging
to mucosal sunaces of the airways leading to the lungs. These
passages are covered with cilia, brushlike structures that nor-
mally sweep debris away from the lungs. The surface of Bor-
detella bristles with proteins, called adhesins, that attach to
sugar molecules at the base of the cilia. Dr. Tuomanen is
working on biochemical means for preventing this attachment.
She has been able to block the attachment in the test tube by
using antibodies that cover the anchoring sites on human cells.
Alternately, bacteria treated with sugars that look like the
anchoring site bind the sugar instead of the cell. Both ap-
proaches are now being tested in animals.
"People often think of a laboratory as a remote, unreal place,"
Dr. Tomasz reflects. "But for us the opposite seems true. The
story of pneumococcus is about the closeness of the world of
test tubes and research and the' real' world ofclinics and medicine.
For all the interesting insights into basic biology that pneumococ-
cus has given us, I think that the most exciting ones are yet to
come as we try to understand disease in molecular terms." 0
Bordetella pertussis (Bp), the
bacterium responsible for
whooping cough, attaching to the
base of a cilium (C) of an
epithelial cell from the lining of
the airways to the lungs.
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